Analyst Ratings published Tuesday March 10th 2026

3/10/26	Upgrades	Neutral Buy	X
ALEC Alector BTIG Research
$6
3/10/26	Initiated	Hold	X
AMGN Amgen Jefferies
$350
3/10/26	Upgrades	Hold Buy	X
ARGX argenx Deutsche Bank
3/10/26	Initiated	Outperform	X
BBIO BridgeBio Pharma William Blair
3/10/26	Upgrades	Hold Buy	X
CLRB Cellectar Biosciences Maxim Group
$10
3/10/26	Initiated	Neutral	X
CROX Crocs BTIG Research
3/10/26	Upgrades	Eq-Weight Overweight	X
CRWD CrowdStrike Morgan Stanley
$510
3/10/26	Downgrades	Buy Neutral	X
DAWN Day One Biopharmaceuticals H.C. Wainwright
$21.50
3/10/26	Initiated	Overweight	X
DY Dycom Cantor Fitzgerald
$436
3/10/26	Initiated	Overweight	X
EME EMCOR Group Cantor Fitzgerald
$848
3/10/26	Upgrades	Sec Weight Overweight	X
FSS Federal Signal KeyBanc Capital Markets
$130
3/10/26	Initiated	Buy	X
GILD Gilead Sciences Jefferies
$180
3/10/26	Upgrades	Underperform Neutral	X
HIMS Hims & Hers Health BofA Securities
$23
3/10/26	Upgrades	Sell Neutral	X
HIMS Hims & Hers Health Citigroup
$24
3/10/26	Upgrades	Neutral Buy	X
INTU Intuit Rothschild & Co Redburn
$700
3/10/26	Initiated	Buy	X
KPTI Karyopharm Therapeutics Rodman & Renshaw
$28
3/10/26	Initiated	Buy	X
LTH Life Time Jefferies
$40
3/10/26	Initiated	Buy	X
MSTR Strategy Inc B. Riley Securities
$175
3/10/26	Downgrades	Buy Hold	X
NVO Novo Nordisk A/S TD Cowen
$42
3/10/26	Resumed	Underperform	X
QCOM Qualcomm BofA Securities
$145
3/10/26	Upgrades	Hold Buy	X
RIVN Rivian Automotive TD Cowen
$20
3/10/26	Initiated	Buy	X
RKT Rocket Companies Compass Point
$21
3/10/26	Upgrades	Underperform Neutral	X
SEDG SolarEdge Technologies BofA Securities
$40
3/10/26	Upgrades	Neutral Buy	X
SLRC SLR Capital Partners Compass Point
$16.50
3/10/26	Upgrades	Sell Neutral	X
T AT&T Arete
$28
3/10/26	Upgrades	Hold Buy	X
TDOC Teladoc Deutsche Bank
$11
3/10/26	Upgrades	Neutral Buy	X
TU Telus BofA Securities
$16
3/10/26	Resumed	Buy	X
USPH U.S. Physical Therapy Jefferies
$102
3/10/26	Initiated	Buy	X
UWMC UWM Holdings Compass Point
$8.50
3/10/26	Initiated	Buy	X
VRTX Vertex Pharma Jefferies
$580
3/10/26	Reiterated	Outperform	X
VRTX Vertex Pharma Oppenheimer
$540 $600
3/10/26	Resumed	Buy	X
WSFS WSFS Financial Brean Capital
$74.50